Search

Your search keyword '"Dorota Zarębska-Michaluk"' showing total 16 results
Start Over Author "Dorota Zarębska-Michaluk" Journal journal of hepatology
16 results on '"Dorota Zarębska-Michaluk"'

2. Real-life efficacy and safety of direct-acting antivirals in patients with liver cirrhosis and history of hepatic decompensation: EpiTer-2 study

Author

Berkan-Kawinprimeska, Aleksandra, Anna, Piekarska, Dorota Zarębska-Michaluk, Sitko, Marek, Garlicki, Aleksander, Berak, Hanna, Andrzej, Horban, Janczewska, Ewa, Czauz-Andrzejuk, Agnieszka, Mazur, Wlodzimierz, Tudrujek, Magdalena, Tomasiewicz, Krzysztof, Dobracka, Beata, Orlowska, Iwona, Krzysztof, Simon, Pabjan, Pawel, Socha, Lukasz, Laurans, Lukasz, Dybowska, Dorota, Halota, Waldemar, Pawlowska, Malgorzata, Lorenc, Beata, Jaroszewicz, Jerzy, and Flisiak, Robert

Subjects
Hepatology
Published
2020
Full Text
View/download PDF

3. THU-185-Effectiveness and safety of DAA-based treatment of hepatitis C patients with severe and end stage chronic kidney diseases-EpiTer-2 database analysis

Author

Rafał Krygier, Dorota Zarębska-Michaluk, Tronina Olga, Klapaczynski Jakub, Simon Krzysztof, Ewa Janczewska, Robert Flisiak, Jolanta Citko, Aleksander Garlicki, Beata Lorenc, Jerzy Jaroszewicz, Matgorzata Pawtowska, Piekarska Anna, Krzysztof Tomasiewicz, Magdalena Tudrujek, Dorota Dybowska, Wtodzimierz Mazur, Agnieszka Czauż-Andrzejuk, Witold Dobracki, Waldemar Halota, and Jolanta Białkowska-Warzecha

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Database analysis, Chronic Kidney Diseases, Medicine, Hepatitis C, Stage (cooking), business, medicine.disease
Published
2019
Full Text
View/download PDF

4. THU-140-Characteristics of patients and effectiveness of chronic hepatitis C treatment during the initial 4 years of access to interferon-free therapy

Author

Jolanta Citko, Teresa Belica-Wdowik, Agnieszka Czauż-Andrzejuk, Włodzimierz Mazur, Jolanta Białkowska-Warzecha, Piekarska Anna, Dobracka Beata, Łukasz Socha, Dorota Zarębska-Michaluk, Marek Sitko, Hanna Berak, Matgorzata Pawłowska, Krzysztof Tomasiewicz, Deron Zbigniew, Beata Lorenc, Robert Flisiak, Waldemar Halota, Simon Krzysztof, Iwona Orłowska, Magdalena Tudrujek, Dorota Dybowska, Tronina Olga, Rafał Krygier, Jerzy Jaroszewicz, Ewa Janczewska, Łukasz Laurans, and Klapaczynski Jakub

Subjects
medicine.medical_specialty, Hepatology, Chronic hepatitis, business.industry, Internal medicine, Interferon free, medicine, business, Gastroenterology
Published
2019
Full Text
View/download PDF

5. Real world experience with twelve weeks of therapy without ribavirin in genotype 1 HCV infected compensated cirrhotics

Author

Dorota Zarębska-Michaluk, Andrzej Gietka, Łukasz Socha, Marta Wawrzynowicz-Syczewska, I. Ortowska, Ewa Janczewska, Łukasz Laurans, A. Staniaszek, Magdalena Tudrujek, Aleksander Garlicki, Krzysztof Tomasiewicz, M. Pawtowska, Beata Lorenc, Jerzy Jaroszewicz, Marek Sitko, Jolanta Białkowska-Warzecha, Barbara Baka-Ćwierz, Anna Piekarska, H. Andrzej, Deron Zbigniew, Robert Flisiak, Jolanta Citko, Agnieszka Czauż-Andrzejuk, Rafał Krygier, Beata Dobracka, M. Wtodzimierz, Dorota Dybowska, Simon Krzysztof, Teresa Belica-Wdowik, Hanna Berak, and Waldemar Halota

Subjects
medicine.medical_specialty, chemistry.chemical_compound, Hepatology, chemistry, business.industry, Internal medicine, Ribavirin, Genotype, medicine, business, Gastroenterology
Published
2018
Full Text
View/download PDF

6. Sofosbuvir-based treatment of viral hepatitis C genotype 3 infection – A Polish real-world study

Author

Andrzej Gietka, Dorota Dybowska, Jolanta Białkowska-Warzecha, A. Staniaszek, Robert Flisiak, M. Pawtowska, Łukasz Socha, Anna Piekarska, Marta Wawrzynowicz-Syczewska, H. Andrzej, Agnieszka Czauż-Andrzejuk, Dorota Zarębska-Michaluk, Magdalena Tudrujek, Krzysztof Tomasiewicz, Marek Sitko, Barbara Baka-Ćwierz, Łukasz Laurans, Hanna Berak, Teresa Belica-Wdowik, I. Ortowska, Beata Lorenc, Simon Krzysztof, Beata Dobracka, M. Wtodzimierz, Waldemar Halota, Ewa Janczewska, Deron Zbigniew, Jerzy Jaroszewicz, Tronina Olga, and Aleksander Garlicki

Subjects
Hepatology, Sofosbuvir, business.industry, Genotype, medicine, Viral hepatitis, medicine.disease, business, Virology, medicine.drug
Published
2018
Full Text
View/download PDF

7. THU-217-Low risk of HBV reactivation in a large European cohort of HBV/ HCV coinfected patients treated with DAA

Author

Małgorzata Pawłowska, Rafał Krygier, Magdalena Tudrujek, Anna Piekarska, Iwona Buczyńska, Hanna Berak, Beata Dobracka, Dorota Dybowska, Krzysztof Tomasiewicz, Jerzy Jaroszewicz, Dorota Zarębska-Michaluk, Tronina Olga, Simon Krzysztof, Jolanta Białkowska-Warzecha, Waldemar Halota, Łukasz Socha, Aleksander Garlicki, Teresa Belica-Wdowik, Beata Lorenc, Deron Zbigniew, Klapaczynski Jakub, Jolanta Citko, Agnieszka Czauż-Andrzejuk, Włodzimierz Mazur, Ewa Janczewska, Robert Flisiak, and Maciej Piasecki

Subjects
Hepatology, business.industry, Cohort, Hbv reactivation, Medicine, business, Virology
Published
2019
Full Text
View/download PDF

8. THU-139-Real world experience of chronic hepatitis C retreatment with genotype specific regimens in non-responders to previous interferon-free therapy

Author

Marek Sitko, Magdalena Tudrujek, Iwona Orłowska, Klapaczynski Jakub, Robert Flisiak, Tronina Olga, Dorota Dybowska, Włodzimierz Mazur, Simon Krzysztof, Ewa Janczewska, Witold Dobracki, Łukasz Socha, Jerzy Jaroszewicz, Łukasz Laurans, Paweł Pabjan, and Dorota Zarębska-Michaluk

Subjects
Non responders, medicine.medical_specialty, Hepatology, Chronic hepatitis, business.industry, Internal medicine, Interferon free, Genotype, medicine, business, Gastroenterology
Published
2019
Full Text
View/download PDF

9. THU-197-Comparative effectiveness of 8 versus 12 weeks of ombitasvir/paritaprevir/ritonavir and dasabuvir in treatment-naive patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

Author

Dorota Dybowska, Beata Dobracka, Jolanta Białkowska-Warzecha, Iwona Orłowska, Waldemar Halota, Agnieszka Czauż-Andrzejuk, Dorota Zarębska-Michaluk, Jolanta Citko, Włodzimierz Mazur, Aleksander Garlicki, Paweł Pabjan, Krzysztof Tomasiewicz, Marek Sitko, Barbara Baka-Ćwierz, Tronina Olga, Małgorzata Pawłowska, Teresa Belica-Wdowik, Robert Flisiak, Ewa Janczewska, Simon Krzysztof, Deron Zbigniew, Beata Lorenc, Magdalena Tudrujek, Klapaczynski Jakub, Rafał Krygier, Jerzy Jaroszewicz, and Łukasz Laurans

Subjects
medicine.medical_specialty, Dasabuvir, Hepatology, business.industry, Gastroenterology, Therapy naive, chemistry.chemical_compound, chemistry, Genotype 1b, Ombitasvir/paritaprevir/ritonavir, Internal medicine, medicine, Hepatic fibrosis, business
Published
2019
Full Text
View/download PDF

10. The efficacy of paritaprevir/ritonavir/ombitasvir + dasabuvir and ledipasvir/sofosbuvir is similar in patients who failed interferon-based treatment with first generation protease inhibitors

Author

Magdalena Tudrujek, Jerzy Jaroszewicz, Jolanta Białkowska-Warzecha, Iwona Orłowska, Tronina Olga, Rafał Krygier, Agnieszka Czauż-Andrzejuk, Simon Krzysztof, Krzysztof Tomasiewicz, Włodzimierz Mazur, P. Arkadiusz, Hanna Berak, Dorota Zarębska-Michaluk, Małgorzata Pawłowska, Teresa Belica-Wdowik, Jolanta Citko, Andrzej Gietka, Marta Wawrzynowicz-Syczewska, Waldemar Halota, Anna Piekarska, H. Andrzej, Łukasz Socha, Deron Zbigniew, Łukasz Laurans, A. Staniaszek, Dorota Dybowska, Robert Flisiak, Beata Lorenc, Aleksander Garlicki, Marek Sitko, Barbara Baka-Ćwierz, Beata Dobracka, and Ewa Janczewska

Subjects
Dasabuvir, Protease, Hepatology, business.industry, medicine.medical_treatment, Virology, Ombitasvir, First generation, chemistry.chemical_compound, chemistry, Paritaprevir, Interferon, Medicine, In patient, Ritonavir, business, medicine.drug
Published
2018
Full Text
View/download PDF

11. Predictors of Fast Response to Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin in Real Life Amber Study in Genotype 1 and 4 HCV Infected Patients as a Rationale for Shortening of Treatment

Author

Jolanta Białkowska, M. Lucejko, Maciej Jabłkowski, Marta Wawrzynowicz-Syczewska, Magdalena Tudrujek, Iwona Mozer-Lisewska, Waldemar Halota, Ewa Karpińska, A. Grabinska, Ewa Janczewska, Krzysztof Tomasiewicz, Alicja Wiercińska-Drapało, Dorota Zarębska-Michaluk, Khalil Nazzal, K. Rostkowska, Anna Piekarska, Brygida Knysz, Katarzyna Fleischer-Stępniewska, Robert Flisiak, Hanna Berak, Wiesław Kryczka, Jerzy Jaroszewicz, Beata Bolewska, Arkadiusz Pisula, Aleksander Garlicki, Olga Tronina, Kornelia Karwowska, and Andrzej Horban

Subjects
Hepatology, business.industry, Ribavirin, Virology, Ombitasvir/Paritaprevir/ Ritonavir/Dasabuvir, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Genotype, In real life, Medicine, 030211 gastroenterology & hepatology, 030212 general & internal medicine, business
Published
2016
Full Text
View/download PDF

12. 816 RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR CONTAINING TRIPLE THERAPY DOES NOT AFFECT EARLY VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS

Author

Andrzej Horban, T. Lapinski, I. Olszok, W. Lojewski, K. Jurczyk, Hanna Berak, Dorota Zarębska-Michaluk, J. Wroblewski, Wiesław Kryczka, Beata Dobracka, Joanna Musialik, Dorota Kozielewicz, M. Librant-Suska, Robert Flisiak, A. Ruszala, Ewa Janczewska, K. Augustyniak, B. Postawa-Klosinska, Arkadiusz Pisula, Witold Dobracki, and M. Dudziak

Subjects
medicine.medical_specialty, Hepatology, business.industry, Liver fibrosis, Ribavirin, Affect (psychology), Gastroenterology, Telaprevir, Non responders, chemistry.chemical_compound, chemistry, Virologic response, Internal medicine, Medicine, Dose reduction, business, medicine.drug
Published
2013
Full Text
View/download PDF

13. P1169 EFFECT OF PEGYLATED INTERFERON OR RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR BASED THERAPY ON SVR12 IN NULL-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS (ADVEX STUDY)

Author

K. Jurczyk, J. Wroblewski, Dorota Kozielewicz, Ewa Janczewska, M. Dudziak, B. Postawa-Klosinska, Beata Dobracka, Robert Flisiak, Witold Dobracki, Andrzej Horban, Wiesław Kryczka, Hanna Berak, W. Lojewski, Dorota Zarębska-Michaluk, Arkadiusz Pisula, K. Augustyniak, I. Olszok, T. Lapinski, Joanna Musialik, M. Librant-Suska, and A. Ruszala

Subjects
medicine.medical_specialty, Hepatology, business.industry, Ribavirin, Liver fibrosis, Null (mathematics), Gastroenterology, Telaprevir, chemistry.chemical_compound, chemistry, Pegylated interferon, Internal medicine, Medicine, Dose reduction, business, medicine.drug
Published
2014
Full Text
View/download PDF

14. 748 EFFICACY OF STANDARD OF CARE THERAPY FOLLOWING EXPERIMENTAL DEBIO 025 TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

Author

Robert Flisiak, Andrzej Horban, J. Kierkus, J. Liz, R. Crabbe, Dorota Zarębska-Michaluk, Waldemar Halota, Małgorzata Pawłowska, Wiesław Kryczka, Marek Woynarowski, Jolanta Białkowska, Agnieszka Czauż-Andrzejuk, and Maciej Jabłkowski

Subjects
medicine.medical_specialty, Standard of care, Hepatology, Chronic hepatitis, business.industry, Internal medicine, medicine, In patient, business
Published
2010
Full Text
View/download PDF

15. Drug-induced acute hepatitis

Author

Wiesław Kryczka, E. Dutkiewicz, J. Kubicka, and Dorota Zarębska-Michaluk

Subjects
Drug, medicine.medical_specialty, Hepatology, business.industry, media_common.quotation_subject, Internal medicine, Medicine, business, Gastroenterology, media_common, Acute hepatitis
Published
1998
Full Text
View/download PDF

16. Outcome of acute hepatitis B and C

Author

J. Medyńska, Wiesław Kryczka, E. Dutkiewicz, and Dorota Zarębska-Michaluk

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, medicine, Acute hepatitis B, business, Outcome (game theory), Gastroenterology
Published
1998
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results